Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Purchased by United Capital Financial Advisers LLC

United Capital Financial Advisers LLC boosted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating) by 5.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 144,336 shares of the pharmacy operator’s stock after purchasing an additional 7,339 shares during the period. United Capital Financial Advisers LLC’s holdings in Walgreens Boots Alliance were worth $5,470,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. BlackRock Inc. grew its stake in shares of Walgreens Boots Alliance by 4.9% during the first quarter. BlackRock Inc. now owns 57,751,600 shares of the pharmacy operator’s stock valued at $2,585,537,000 after acquiring an additional 2,719,081 shares in the last quarter. State Street Corp grew its stake in shares of Walgreens Boots Alliance by 6.2% during the first quarter. State Street Corp now owns 49,822,222 shares of the pharmacy operator’s stock valued at $2,230,541,000 after acquiring an additional 2,911,384 shares in the last quarter. Invesco Ltd. grew its stake in shares of Walgreens Boots Alliance by 7.1% during the first quarter. Invesco Ltd. now owns 9,124,025 shares of the pharmacy operator’s stock valued at $408,481,000 after acquiring an additional 601,844 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of Walgreens Boots Alliance by 4.7% during the first quarter. Bank of New York Mellon Corp now owns 7,170,451 shares of the pharmacy operator’s stock valued at $321,022,000 after acquiring an additional 323,397 shares in the last quarter. Finally, Federated Hermes Inc. grew its stake in shares of Walgreens Boots Alliance by 76.3% during the first quarter. Federated Hermes Inc. now owns 5,229,343 shares of the pharmacy operator’s stock valued at $234,118,000 after acquiring an additional 2,263,629 shares in the last quarter. 57.33% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Nancy M. Schlichting sold 16,570 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 17th. The stock was sold at an average price of $39.89, for a total transaction of $660,977.30. Following the sale, the director now owns 5,515 shares of the company’s stock, valued at $219,993.35. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other news, Director Nancy M. Schlichting sold 16,570 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 17th. The stock was sold at an average price of $39.89, for a total transaction of $660,977.30. Following the sale, the director now owns 5,515 shares of the company’s stock, valued at $219,993.35. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Kevin M. Ban sold 10,303 shares of Walgreens Boots Alliance stock in a transaction that occurred on Friday, November 18th. The shares were sold at an average price of $40.19, for a total value of $414,077.57. Following the sale, the executive vice president now directly owns 27,916 shares in the company, valued at approximately $1,121,944.04. The disclosure for this sale can be found here. Corporate insiders own 17.40% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA opened at $41.76 on Thursday. The company has a quick ratio of 0.38, a current ratio of 0.75 and a debt-to-equity ratio of 0.36. The firm’s 50-day moving average price is $35.22 and its two-hundred day moving average price is $38.10. Walgreens Boots Alliance, Inc. has a 52-week low of $30.39 and a 52-week high of $55.00. The stock has a market capitalization of $36.11 billion, a P/E ratio of 8.35, a P/E/G ratio of 1.86 and a beta of 0.71.

Walgreens Boots Alliance (NASDAQ:WBAGet Rating) last released its quarterly earnings results on Thursday, October 13th. The pharmacy operator reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.77 by $0.03. The company had revenue of $32.45 billion for the quarter, compared to analysts’ expectations of $32.17 billion. Walgreens Boots Alliance had a return on equity of 14.39% and a net margin of 3.27%. The business’s revenue for the quarter was down 5.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.17 earnings per share. As a group, sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 4.5 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 12th. Stockholders of record on Tuesday, November 15th will be issued a dividend of $0.48 per share. The ex-dividend date of this dividend is Monday, November 14th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 4.60%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 38.40%.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Evercore ISI lowered their target price on Walgreens Boots Alliance from $41.00 to $32.00 and set an “in-line” rating for the company in a research note on Monday, October 3rd. UBS Group decreased their price target on Walgreens Boots Alliance from $40.00 to $37.00 and set a “neutral” rating for the company in a research note on Friday, October 7th. Cowen upgraded Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $43.00 to $54.00 in a research note on Tuesday. Morgan Stanley reiterated an “underweight” rating and issued a $39.00 price target on shares of Walgreens Boots Alliance in a research note on Wednesday. Finally, Royal Bank of Canada decreased their price target on Walgreens Boots Alliance from $42.00 to $36.00 and set a “sector perform” rating for the company in a research note on Wednesday, October 19th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $43.23.

Walgreens Boots Alliance Profile

(Get Rating)

Walgreens Boots Alliance, Inc operates as an integrated healthcare, pharmacy, and retailer in the United States (U.S.), the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Featured Articles

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAGet Rating).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.